Abrogation of the NRF2-NOTCH3 axis by disrupting the NOTCH3 enhancer suppressed oncosphere growth of NRF2-activated NSCLC cell lines (Fig. 9a and Supplementary Fig. 11a, b). The gene discussed is NOTCH3; the disease is non-small cell lung carcinoma.